• SHOP
    • COMBOS
    • TESTIMONIALS
    • CART
    • INGREDIENTS
      • 2-DEOXY-D-GLUCOSE (2DG)
      • ACACIA CYANOPHYLLA FLOWER
      • ACORI GRAMINEI RHIZOMA
      • AEGLE MARMELOS CORREA
      • AGARICUS BLAZEI
      • AGED GARLIC EXTRACT
      • AFRAMOMUM MELEGUETA
      • ALOE ARBORESCENS
      • ALBIZIA
      • ALPINIA OFFICINARUM
      • ALTERNANTHERA SESSILIS
      • AMERICAN GINSENG
      • AMYGDALIN
      • ANACYCLUS PYRETHRUM
      • ANGELICA ARCHANGELICA
      • ANGELICA SINENSIS
      • ANTRODIA
      • APIGENIN
      • ARTICHOKE LEAF
      • ARTOCARPIN
      • AJUGA TURKESTANICA
      • ASHWAGANDHA
      • ASPALATHIN
      • ASTRAGALUS COMPLANATUS
      • AVENA SATIVA
      • BACOPA MONNIERI
      • BAVACHIN
      • BEE POLLEN
      • BETULINIC ACID
      • BOSWELLIC ACID
      • BREVILIN A
      • CAMPESTEROL
      • CAPSAICIN
      • CARCININE
      • CASTICIN
      • CHRYSIN
      • CIANIDANOL
      • CINNAMOMUM ZEYLANICUM
      • CITRULLUS COLOCYNTHIS
      • CITRUS RETICULATA PEEL
      • CODONOPSIS
      • CONJUGATED LINOLEIC ACID
      • COSTUNOLIDE
      • CYANIDIN
      • CUCURBITACIN D
      • DAIDZEIN
      • DECURSIN
      • DELPHINIDIN
      • DIGITALIS PURPREA (DIGOXIN)
      • DIOSMIN
      • ELLAGIC ACID
      • EMBELIN
      • ERIODICTYOL
      • GALLIC ACID
      • GLYCITEIN
      • GLYCYRRHIZIN
      • HYPERFORIN
      • ICARIIN
      • ISORHAMNETIN
      • ISOORIENTIN
      • ISOVITEXIN
      • JACEOSIDIN
      • KAEMPFEROL
      • KIGELIA AFRICANA
      • KURARINONE
      • LEMON BALM
      • LICORICIDIN
      • LIPOIC ACID
      • LUPEOL
      • MAGNOLOL
      • MULBERRY LEAF
      • NARINGENIN
      • NOBILETIN
      • OLEACEIN
      • OLEANOLIC ACID
      • OLIVE OIL
      • ORIDONIN
      • PARTHENOLIDE
      • PHLOROGLUCINOL
      • PHLORIZIN
      • PICEATANNOL
      • PRISTIMERIN
      • PROANTHOCYANIDINS
      • PROCYANIDIN B3
      • PSEUDOLARIC ACID B
      • PTEROSTILBENE
      • RUTIN
      • SOLIDAGO VIRGAUREA
      • TANGERETIN
      • TARAXASTEROL
      • TRICHOSTATIN A
      • WEDELOLACTONE
      • WOGONIN
      • YERBA MATE
    • ABOUT
    • SCIENTIFIC STUDIES
      • ADAPTOGENS
      • ADIPOCYTE APOPTOSIS (KILLING FAT CELLS)
      • ADDICTION AND THE BRAIN
      • ADDICTION & STRESS
      • ADDICTION WITHDRAWAL
      • ADIPOCYTE DEDIFFERENTIATION (THE REVERSAL OF FAT FORMATION)
      • ADIPOCYTE DIFFERENTIATION
      • ALLERGIES & CYTOKINES
      • ALDOSTERONE & OBESITY/HYPERTENSION
      • ALZHEIMER’S, DEMENTIA, PARKINSON’S
      • ANTI-ACNE EFFECT OF FLAVONOIDS AND POLYPHENOLS
      • ADVANCED GLYCATION END PRODUCTS (AGES)
      • ADDICTION TREATMENT
      • AMPK
      • ANTI AGING
      • ANTIAGING EFFECTS OF COFFEE
      • ANTI-AGING EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-APOPTOTIC PATHWAYS
      • ANTI ATHEROGENIC
      • ANTI-CANCER EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI CARIOGENIC (Protecting From Tooth Decay)
      • ANTI COVID-19 EFFECTS OF MEDICINAL PLANTS, FLAVONOIDS & POLYPHENOLS
      • ANTI GLYCATIVE
      • ANTI GLYCATION AGENTS
      • ANTI-INFLAMMATORY EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI-VIRAL EFFECTS OF FLAVONOIDS & POLYPHENOLS
      • ANTI WRINKLE AGENTS
      • APOPTOSIS
      • APOPTOSIS IN 3T3-L1
      • AUTOPHAGY
      • BCL-2
      • BCL-W
      • BCL-XL
      • BDNF
      • BECLIN-1 & AUTOPHAGY
      • BH3 MIMETICS
      • BIM aka BCL2L11
      • BMI-1
      • BRASSINOSTEROIDS
      • CALORIE RESTRICTION
      • CALORIE RESTRICTION & LIFESPAN EXTENSION
      • CARBAMYLATION
      • CARBONYL SCAVENGER
      • CARBONYL STRESS
      • CARDIOPROTECTIVE AGENTS
      • CARDIAC GLYCOSIDES
      • CATALASE
      • CELL CYCLE ARREST
      • CENTENARIANS
      • CHOLESTEROL EFFLUX
      • COGNITIVE ENHANCEMENT
      • COLD SHOCK PROTEINS
      • COLD-INDUCIBLE RNA-BINDING PROTEIN (CIRBP) & DNA REPAIR
      • CONDITIONED PLACE PREFERENCE
      • CORTICOTROPIN RELEASING FACTOR
      • CRYOTHERAPY
      • CRYOLIPOLYSIS: FREEZING FAT TO DEATH
      • CYP2E1
      • CYTOKINES IN PAIN, INFLAMMATION & AGING
      • DAF-16
      • DIABETES & CANCER
      • DIHYDROTESTOSTERONE (DHT)
      • DNA METHYLATION & AGING
      • DNA REPAIR
      • DNA REPAIR VIA FLAVONOIDS & POLYPHENOLS
      • ADDICTION & DOPAMINE
      • DRY FASTING AND FLUID RESTRICTION FASTING
      • DYNORPHIN
      • ELLAGITANNINS
      • ENLARGED HEART AND CARDIOMEGALY
      • EPIGENETIC MODIFIERS
      • EPINEPHRINE
      • ERGOGENIC AGENTS (INCREASE ATHLETIC PERFORMANCE)
      • EXCITOXICITY & THE BRAIN
      • EXTRACELLULAR MATRIX STIFFENING (10TH HALLMARK OF AGING)
      • EXTENDS LIFESPAN
      • EXTINCTION TRAINING
      • FASTING BRAIN
      • FASTING CANCER
      • FASTING & CANCER
      • FASTING MIMICKING DIET
      • FEAR EXTINCTION
      • FGF21
      • FLAVONES
      • GABA (γ-AMINOBUTYRIC ACID)
      • GALLOTANNINS
      • GLUCONEOGENESIS
      • GLUTAMATE & BRAIN
      • GLYCATION
      • KLOTHO
      • FASTING, CALORIE RESTRICTION & EXTENDING LIFESPAN
      • FOXO3
      • FOXO4
      • HALLMARKS OF AGING
      • HEPATOPROTECTIVE AGENTS (KEEPING LIVER HEALTHY)
      • HMGB1
      • HORMESIS
      • HPA AXIS
      • HSP70, THE ANTI-AGING PROTEIN
      • HSP90 INHIBITORS
      • HYPERGLYCEMIA
      • HYPERINSULINEMIA
      • HYPOACTIVE SEXUAL DESIRE (WHY PEOPLE HAVE ZERO SEX DRIVE)
      • HYPOCRETIN OREXIN
      • IKK
      • IL-6/STAT3
      • IRISIN
      • ISOFLAVONES
      • IMMUNOSENESCENCE
      • INCREASE PROTEIN SYNTHESIS
      • INFECTOBESITY
      • INFLAMMATION & ANXIETY
      • INFLAMMATION & CANCER
      • INFLAMMATION & DEPRESSION
      • INFLAMMATION & OBESITY
      • INFLAMMAGING
      • INHIBITION OF RENAL GLUCOSE REABSORPTION
      • INSULIN & AGING
      • INSULIN & CANCER: HOW INSULIN LITERALLY PROTECTS CANCER CELLS FROM BEING KILLED
      • INSULIN & MTOR
      • INSULIN & OBESITY
      • INTERMITTENT FASTING
      • JAK INHIBITION ALLEVIATES SASP
      • JNK ACTIVATION PREVENTS PREMATURE SENESCENCE
      • KETONE BODIES
      • KETOGENIC DIET
      • LEYDIG CELL STEROIDOGENESIS
      • LIFESPAN EXTENSION
      • LIPOLYTIC AGENTS
      • LIPID DROPLETS
      • LIPOLYSIS (THE DECOMPOSITION OF BODY FAT)
      • LOWERING CHOLESTEROL THRU FASTING, DIET & MEDICINAL PLANTS
      • MATRIX METALLOPROTEINASES (MMPs)
      • MCL-1
      • MDM2 INHIBITION AS SASP INHIBITOR
      • MEDITERRANEAN DIET
      • MENAQUINONE 4
      • METABOLIC REPROGRAMMING
      • METABOLIC SYNDROME EXTRACT
      • METHIONINE RESTRICTION
      • MITOCHONDRIAL UNCOUPLING
      • MONKEYPOX
      • MSG (MONOSOSODIUM GLUTAMATE)
      • MUSCLE FORCE PRODUCTION
      • MUSCLE ATROPHY (PREVENTING)
      • MYOGENESIS
      • MYOSTATIN INHIBITION
      • MYOSTATIN INHIBITION PRESERVES MUSCLE
      • mTORC2
      • mTOR: THE RAPID AGING PATHWAY
      • NATURAL ANTICOAGULANTS
      • NATURAL AROMATASE INHIBITORS
      • NEUROGENESIS (GROWING NEW BRAIN CELLS)
      • NEUROCHEMISTRY OF ADDICTION
      • NEUROPLASTICITY
      • NEUROINFLAMMATION
      • NEUROPROTECTIVE AGENTS
      • NMDA & ANXIETY & DEPRESSION
      • NMDA RECEPTOR AND FEAR
      • NON-OPIOID ANALGESICS (PLANT BASED)
      • NOOTROPICS
      • NORADRENERGIC
      • NOREPINEPHRINE
      • NRF2: MASTER REGULATOR OF THE AGING PROCESS
      • NF-KB
      • ONCOGENE ACTIVATION INDUCED SENESCENCE
      • OVERNUTRITION
      • OXIDATIVE STRESS & AGING
      • P16INK4A
      • P38MAPK
      • P53: TUMOR SUPRESSOR
      • PERIODONTITIS
      • PHYTOCHEMICALS
      • PHYTOSTEROLS
      • PHYTOSTANOLS
      • PHYTOECDYSTEROIDS
      • PROANTHOCYANIDINS
      • PROTEIN CARBONYLATION
      • POLYAMINES & THEIR EFFECT ON BRAIN (NMDA, DEPRESSION, SUICIDE RISK)
      • PPARY2
      • PREMATURE SENESCENCE
      • PREVENTING SKIN AGING
      • PUFAS
      • PURGATIVES
      • RAPAMYCIN (MTOR INHIBITION)
      • RECEPTOR “Κ OPIOID”
      • RED WINE
      • RENAL (KIDNEY) PROTECTIVE AGENTS
      • REMINERALIZATION OF TEETH
      • REPAIR OF DNA BREAKS “DOUBLE STRAND”
      • RESTORE INSULIN SENSITIVITY
      • SASP & ADIPOSE TISSUE
      • SENESCENT CELLS, SASP & SENOLYTICS
      • SENESCENCE-BETA-GALACTOSIDASE (SA-β-gal or SABG)
      • SGLT2 INHIBITORS
      • SGLT2 INHIBITION FOR LIFESPAN EXTENSION
      • SHBG
      • SIRT1
      • SKELETAL MUSCLE HYPERTROPHY (THE SCIENCE OF BUILDING MUSCLE)
      • SKIN ELASTICITY
      • SKIN PHOTOAGING (Preventing & Repairing)
      • SLEEP DEPRIVATION AS THERAPY FOR DEPRESSION
      • SIRT1 & LONGEVITY
      • SMALLPOX
      • SUGAR & AGING
      • STAR PROTEIN
      • STAT3
      • STEM CELL EXHAUSTION
      • STEM CELL REGENERATION
      • STEM CELL THERAPY
      • STIMULATED LIPOLYSYS
      • STEROIDOGENESIS (THE PRODUCTION OF HORMONES IN BODY)
      • STREPTOCOCCUS MUTANS (MAIN BACTERIA BEHIND TOOTH DECAY)
      • STRESS & AGING
      • STRESS & THE BRAIN
      • TELOMERE SHORTENING & PREMATURE AGING
      • TIME RESTRICTED FEEDING
      • TRAUMATIC BRAIN INJURY (HEALING)
      • TRYPTOPHAN HYDROXYLASE 2
      • VISCERAL ADIPOSITY
    • HOME
    • CONTACT
    • INTERSTELLAR 88/8: EXTREME WEIGHTLOSS PROTOCOL
    • The Ultimate Dry Fasting Resource
    0
    CYP2E1
    September 1, 2020
    ANTI-ACNE EFFECT OF FLAVONOIDS & POLYPHENOLS
    September 9, 2020

    SCIENTIFIC STUDIES

    1. 2-Methyl-3-Phenylaminomethylquinolin-4-One As Potential Antidepressant With Nootropic Properties
    2. A Brief Introduction Of Docosahexaenoic Acid And Its Nootropic Effect [J]
    3. A Carbon-13 Nmr Spin-Lattice Relaxation Study Of The Molecular Conformation Of The Nootropic Drug 2-Oxopyrrolidin-1-Ylacetamide
    4. A Clinical And Neurophysiological Trial On Nootropic Drugs In Patients With Mental Decline.
    5. A Combination Of Nootropic Ingredients (Caf+) Is Not Better Than Caffeine In Improving Cognitive Functions
    6. A Comparative Analysis Of The Effect Of Nootropic Preparations With Different Chemical Structures On The Failure Of The Escape Reaction In Rats
    7. A Comparative Study Of The Nootropic Properties Of Piracetam And Oxiracetam
    8. A Natural And Broad Spectrum Nootropic Substance For Treatment Of Sdat–The Ginkgo Biloba Extract.
    9. A Natural And Broad—Spectrum Nootropic Substance For Treatment Of Sdat—The Ginkgo Biloba Extract
    10. A New Method For Testing The Psychopharmacologic Pupil Oscillation Hypothesis Following Administration Of A Nootropic Substance
    11. A New Nootropic Aniracetam: Its Prevention Of Scopolamine-Induced Retrograde Amnesia And Its Possible Action Mechanisms
    12. A New Substance With Nootropic Activity–N-5 (Hydroxynicotinoyl)-L-Glutamic Acid
    13. A Nootropic Adrenocorticotropin Analog 4-10-Semax (L5 Years Experience In Its Design And Study)
    14. A Novel Effect Of Bifemelane, A Nootropic Drug, On Intracellular Ca2+ Levels In Rat Cerebral Astrocytes
    15. A Practical Synthesis Of The Chinese” Nootropic ” Agent Huperzine A: A Possible Lead In The Treatment Of Alzheimer’S Disease
    16. A Simple & Effective Pre-Workout Nootropic Stack That Won’T Break The Bank
    17. A Simplified Route To A Key Intermediate In The Synthesis Of The Chinese Nootropic Agent Huperzine A
    18. A Study Of Nootropic Drugs For Anti-Anxiety Action.
    19. A Study On Nootropic Activity Of Methanolic Extract Of Brassica Oleraceae Var. Caulorapa Bulb In Rodents
    20. A Study To Evaluate The Effect Of Nootropic Drug—Piracetam On Dna Damage In Leukocytes And Macrophages
    21. A Traditional Approach To Herbal Nootropic Agents: An Overview
    22. A Weird Concept With Unusual Fate: Nootropic Drug
    23. Acetylcholinesterase Inhibition In Cognition-Relevant Brain Areas Of Mice Treated With A Nootropic Amazonian Herbal (Marapuama)
    24. Acetylcholinesterase Inhibitory Activity Of Thai Traditional Nootropic Remedy And Its Herbal Ingredients.
    25. Action Mechanism Study Of The Nootropic Peptide Semax For The Development Of New Therapeutic Solutions
    26. Action Of Nootropic Drugs On Transcallosal Responses In Rats
    27. Activity Guided Synthesis And Sar Study Of Flavonols As Nootropic Agents
    28. Adaptogenic And Nootropic Activities Of Aqueous Extract Of Carum Carvi Linn.(Caraway) Fruit: An Experimental Study In Wistar Rats
    29. Adaptogenic And Nootropic Activities Of Aqueous Extract Of Vitis Vinifera (Grape Seed): An Experimental Study In Rat Model
    30. Adaptogenic And Nootropic Activities Of Aqueous Extracts Of Carum Carvi Linn (Caraway) Fruit: An Experimental Study In Wistar Rats
    31. Adaptogenic And Nootropic Activity Of Mimosa Pudica In Albino Wistar Rats
    32. Age-Related Changes Of Cyclic Amp Phosphodiesterase Activity In Rat Brain Regions And A New Phosphodiesterase Inhibitor–Nootropic Agent Adafenoxate.
    33. Age-Related Changes Of The Effects Of A Group Of Nootropic Drugs On The Content Of Rat Brain Biogenic Monoamines.
    34. Age-Related Differences In Memory And In The Memory Effects Of Nootropic Drugs.
    35. Agonist-And Subunit-Dependent Potentiation Of Glutamate Receptors By A Nootropic Drug Aniracetam
    36. Allosteric Potentiation Of Quisqualate Receptors By A Nootropic Drug Aniracetam.
    37. Along-Term-Potentiation-Like’Facilitation Of Hippocampal Synaptic Transmission Induced By The Nootropic Nefiracetam
    38. Alpha Brain Review: Onnit’S Old-School Nootropic Shows Its Age
    39. Ameliorative Influence Of A Nootropic Drug On Motor Activity Of Rats After Bilateral Carotid Artery Occlusion
    40. Amino-Acid Composition And Nootropic Properties Of Polynoophyt
    41. Amycenone, A Nootropic Found In Hericium Erinaceum
    42. An Appraisal Of Medhya Rasayana (Nootropic Herbs) In Present Scenario
    43. An Egg Yolk’S Phospholipid-Pennyroyal Nootropic Nanoformulation Modulates Monoamino Oxidase-A (Mao-A) Activity In Sh-Sy5Y Neuronal Model
    44. An Experimental Study Of Ethanolic Seed Extract Of Vigna Mungo Linn. For Nootropic Activity On Albino Rats
    45. An Investigation Into The Acute Nootropic Effects Of Hypericum Perforatum L.(St. John’S Wort) In Healthy Human Volunteers
    46. Analysis Of Nootropic Used In Our Hospital During 2008-2010
    47. Analysis Of Pharmaceutical Market Of Nootropic Drugs In Ukraine
    48. Analytic Evaluation Of Potential Nootropic Agents
    49. Analyzing Nootropic Effect Of Phyllanthus Reticulatus Poir. On Cognitive Functions, Brain Antioxidant Enzymes And Acetylcholinesterase Activity Against …
    50. Antagonism Of Zn2+ On Nootropic Action Of Piracetam In Mice
    51. Anticonvulsant And Neuroprotective Effects Of The Novel Nootropic Agent Nefiracetam On Kainic Acid-Induced Seizures In Rats
    52. Anticonvulsant Properties Of The Novel Nootropic Agent Nefiracetam In Seizure Models Of Mice And Rats
    53. Antidepressant Activities Of Web 1881, A New Nootropic Agent.
    54. Antidepressant, Psychostimulant, And Nootropic Effects Of Major And Trace Element Composition
    55. Antiepileptic Effects Of Nootropic Agent, Nefiracetam.-In Vivo Study Of Epileptic Mutant, El Mice.
    56. Antihyperglycemic, Antistress And Nootropic Activity Of Roots Of Rubia Cordifolia Linn
    57. Antihypoxic Activity Of 2-Methyl-3-Phenylaminomethylquinolin-4 Of The Perspective Antidepressant With Nootropic …
    58. Antihypoxic Effect Of 3-Hydroxypyridine And Succinic Acid Derivatives And Their Nootropic Action In Alloxan Diabetes
    59. Anti-Inflammatory Properties Of Noopept (Dipeptide Nootropic Agent Gvs-111)
    60. Antioxidant Activity And Flavonoid Composition Of The New Nootropic Preparation Polynoophyt
    61. Anti-Stress And Nootropic Activity Of Aqueous Extract Of Artocarpus Heterophyllus Fruit, And Y-Maze Test In Rodents.
    62. Anti-Stress And Nootropic Activity Of Aqueous Extract Of Piper Longum Fruit, Estimated By Noninvasive Biomarkers And Y-Maze Test In Rodents
    63. Anti-Stress And Nootropic Activity Of Drugs Affecting The Renin-Angiotensin System In Rats Based On Indirect Biochemical Evidence
    64. Anti-Stress Anxiolytic And Nootropic Activity Of Nyctanthes Arbour Tritis Leaves
    65. Anti-Stress, Nootropic And Anticonvulsant Potential Of Fruit Extracts Of Piper Longum L
    66. Anxiolytic Activity Of Endogenous Nootropic Dipeptide Cycloprolylglycine In Elevated Plus-Maze Test
    67. Anxiolytic Activity Of Piracetam, A Nootropic Agent, Following Subchronic
    68. Anxiolytic Activity Of Piracetam, A Nootropic Agent, Following Subchronic Administration In Rodents.
    69. Anxiolytic And Nootropic Activity Of Vetiveria Zizanioides Roots In Mice
    70. Anxiolytic, Nootropic And Anticonvulsant Activity Of Hemidesmus Indicus In Laboratory Animals.
    71. Application Of Nootropic Agents In Complex Treatment Of Patients With Concussion Of The Brain
    72. Are Cb1 Receptor Antagonists Nootropic Or Cognitive Impairing Agents?
    73. Assessing The Validity Of Danio Rerio As A Model Organism For Nootropic Research: The Effects Of Phenylpiracetam On Larval Zebrafish Behavior
    74. Assessment Of Nootropic Activity Of Panchagavya Ghrita In Animal Models
    75. Assessment Of Nootropic And Amnestic Activity Of Centrally Acting Agents
    76. Assessment Of The Prevalence Of Nootropic Drugs By Elderly Patients In Geriatric Practice
    77. Asthenic Syndrome In Clinical Course Of Acute Period Of Brain Concussion During Complex Treatment Using Nootropic Agents
    78. Astrocytes Mediated The Nootropic And Neurotrophic Effects Of Sarsasapogenin-Aa13 Via Upregulating Brain-Derived Neurotrophic Factor
    79. Avoidance Facilitation In Adult Mice By Prenatal Administration Of The Nootropic Drug Oxiracetam
    80. Bacopa Monniera, A Reputed Nootropic Plant: An Overview
    81. Bacopa Monnieri, A Nootropic Drug
    82. Balance And The Nitric Oxide System In The Brain Tissue Of Rats Subjected To Experimental Acute Impairment Of Cerebral Blood Flow: The Therapeutic Effects Of Nootropic …
    83. Bar-Pressing For Water Reward: Effects Of Nootropic Drugs And Peptides On Discrimination Learning In Rats.
    84. Beekeeper’S Naturals Blxr Brain Fuel Review–Is Royal Jelly Even A Nootropic ?
    85. Behavioral And Biochemical Evidences For Nootropic Activity Of Boldine In Young And Aged Mice
    86. Behavioral And Electrophysiological Analysis Of The Choline-Positive Effect Of Nootropic Dipeptide Acylproline (Gvs-111)
    87. Behavioral Pharmacological Studies Of Nootropic Candidates On The Central Dopaminergic Activity Rats
    88. Beneficial Effect Of Sodium Thiosulfate Extends Beyond Myocardial Tissue In Isoproterenol Model Of Infarction: Implication For Nootropic Effects
    89. Beyond Raw Chemistry Labs Nootropic Review: Does It Work?
    90. Bioaccessibility Of The New Dipeptide Nootropic Drug Noopept
    91. Biochemical Studies On The Nootropic Drug Oxiracetam In Brain
    92. Biochemical Studies On The Nootropic Drug, Oxiracetam, In Brain
    93. Biogenic Monoamine Uptake By Rat Brain Synaptosomes During Aging. Effects Of Nootropic Drugs
    94. Blockade Of The Nootropic Action Of Piracetam-Like Nootropic s By Adrenalectomy: An Effect Of Dosage?
    95. Blood Mononuclear Cells As Speculum Of Emotional Stress Analyzed By Synchrotron Infrared Spectroscopy And A Nootropic Drug
    96. Brain Awake Review: Weak Stack With 1 Potent Nootropic
    97. Brain Entry And Direct Central Pharmacological Effects Of The Nootropic Drug Oxiracetam
    98. Brain Neurotransmitter Receptor Binding And Nootropic Studies On Indian Hypericum Perforatum Linn.
    99. Brainflo Review–A Good Nootropic From Bioflourish
    100. Can Nootropic Drugs Be Effective Against The Impact Of Ethanol Teratogenicity On Cognitive Performance?
    101. Can The Pattern Of Neuropsychological Improvement Obtained With Cholinergic Drugs Be Used To Infer A Cholinergic Mechanism In Other Nootropic Drugs?
    102. Cannabis-Induced Impairment Of Learning And Memory: Effect Of Different Nootropic Drugs
    103. Cardiotoxicity Of The Nootropic Supplement, Phenylethylamine
    104. Cell Line Toxicity Study And Pharmacological Screening Of Effective Nootropic Herbal Formulation In Rat
    105. Central Depressant And Nootropic Effects Of Daytime Melatonin In Mice
    106. Changes In Brain Biogenic Monoamines Induced By The Nootropic Drugs Adafenoxate And Meclofenoxate And By Citicholine (Experiments On Rats).
    107. Changes In Sensitivity To Nootropic Drugs In Rats Exposed Pre-And Postnatally To Ethanol
    108. Changes In The Indices Of Neuronal Functional Activity Under The Action Of Piracetam As A Possible Basis For Realizing The Effects Of Nootropic Agents
    109. Changes In The Narrow-Band Components Of The Eeg Spectrum Under The Action Of Nootropic Drugs
    110. Changes Of Dopamine Metabolism By Hypoxia And Effect Of Nootropic Drugs.
    111. Changes Of High-Affinity Choline Uptake In The Hippocampus Of Old Rats After Long-Term Administration Of Two Nootropic Drugs (Tacrine And Ginkgo Biloba Extract)
    112. Characterisation And Quality Assurance Studies On A Nootropic Agent And Ace Inhibitor Using Ftir Spectroscopy
    113. Characteristics Of Antiischemic And Nootropic Properties Of Ademol In A Rat Model Of Acute Brain Ischemia
    114. Characterization Of The Transcallosal Response In Aged Rats And Its Susceptibility To Nootropic Drugs
    115. Chemistry, Pharmacology, And Clinical Efficacy Of The Chinese Nootropic Agent Huperzine A
    116. Citicoline: Is This The Ultimate Natural Nootropic ?
    117. Clinical And Psychometric Evaluation Of The Efficacy Of Nootropic Drugs: Characteristics Of Several Procedures.
    118. Cognishield Review: Over-Priced And Over-Hyped Nootropic
    119. Cognitive Improvement In Clinical Trials With Nootropic Drugs: When Can It Be Expected And How To Clarify Its Meaning
    120. Cognitive Improvement In Clinical Trials With Nootropic Drugs: When Can It Be Expected And How To Clarify Its Meaning.
    121. Cognitive Psychophysiology In Nootropic Drug Research: Effects Of Ginkgo Biloba On Event-Related Potentials (P300) In Age-Associated Memory Impairment
    122. Comment On ‘Large-Scale Cognitive Gwas Meta-Analysis Reveals Tissue-Specific Neural Expression And Potential Nootropic Drug Targets’ By Lam Et Al.
    123. Nootropic s”>Common Misconceptions: Nootropic Vs Cognitive Enhancers
    124. Comparative Analysis Of Nootropic Means Of Consumption In Ukraine, Estonia And Norway
    125. Comparative Assessment Of Nootropic Activity Of Yashtimadhu Choorna And Yashtimadhu Kshirapaka In Young And Aged Mice
    126. Comparative Characteristics Of The Nootropic Action Of Phenibut And Phepyrone.
    127. Comparative Efficiency Of Nootropic Drugs In Complex Treatment Of Patients With Remote Consequences Of Closed Craniocereberal Trauma
    128. Comparative Experimental Research Into The Nootropic Action Of Procaine And Pyracetam.
    129. Comparative Influence Of Nootropic Preparations On The Emetic Effect Of Morphine
    130. Comparative Neurophysiological Study Of The Nootropic Drugs Piracetam And Centrophenoxine
    131. Comparative Nootropic Effect Of Evolvulus Alsinoides And Convolvulus Pluricaulis
    132. Comparative Studies On The Anticonvulsant Effectiveness Of Nootropic Drugs In Kindled Rats.
    133. Comparative Studies On The Effects Of The Nootropic Drug Adafenoxate And Of The Cerebral Vasodilator Flunarizine On Arterial Smooth Muscles.
    134. Comparative Studies On The Effects Of The Nootropic Drugs Adafenoxate, Meclofenoxate And Piracetam, And Of Citicholine On Scopolamine-Impaired Memory, Exploratory …
    135. Comparative Study Of The Neuroprotective And Nootropic Activities Of The Carboxylate And Amide Forms Of The Hldf-6 Peptide In Animal Models Of Alzheimer’S Disease
    136. Comparision Of Nootropic Effects Of Kaixinsan Prescription And Kaixinsan Without Poria Cocos (Schw.) Wolf To Alzheimer’S Mice Model
    137. Comparison Of 1-(2-Naphthyloxymethylcarbonyl) Pyrrolidine, Pp-20/Dpj, Newly Synthesized Compound With The Nootropic Drug Piracetam In Normal And Aluminum …
    138. Comparison Of Nootropic And Neuroprotective Features Of Aryl-Substituted Analogs Of Gamma-Aminobutyric Acid
    139. Computational Analysis Of Theacrine, A Purported Nootropic And Energy-Enhancing Nutritional Supplement
    140. Conceptual Considerations On The Influence Of Medhya Rasayana (Nootropic Drugs) In Cardiovascular Health
    141. Conformation Of The Nootropic Agents 1-(4-Methoxybenzoyl)-5-Oxo-2-Pyrrolidinepropanoic Acid (Ci-933) And 4-Hydroxymethyl-1-Benzyl-Pyrrolidin-2-One (Web-1868) …
    142. Conformational Transitions In The Nootropic Peptide Semax (Mehfpgp) And Its N-Terminal Modifications
    143. Correction To: A Combination Of Nootropic Ingredients (Caf+) Is Not Better Than Caffeine In Improving Cognitive Functions
    144. Correction: The Atypical Stimulant And Nootropic Modafinil Interacts With The Dopamine Transporter In A Different Manner Than Classical Cocaine-Like Inhibitors
    145. Critical Issues In Nootropic Drug Research
    146. Current Aspects Of The Search Of Effective Nootropic Drugs
    147. Cyclic Gmp Mimicks Potentiation Effect Of The Nootropic Agent Vinpocetine On The High Threshold A-Current In The Mollusk Neurons
    148. Delayed Nootropic Effects Of Arginine Vasopressin After Early Postnatal Chronic Administration To Albino Rat Pups
    149. Design And Study Of Some Novel Ibuprofen Derivatives With Potential Nootropic And Neuroprotective Properties
    150. Design, Synthesis And Nootropic Activity Of New Analogues Of Sunifiram And Sapunifiram, Two Potent Cognition-Enhancers
    151. Design, Synthesis, And Preliminary Pharmacological Evaluation Of 1, 4-Diazabicyclo [4.3. 0] Nonan-9-Ones As A New Class Of Highly Potent Nootropic Agents
    152. Designing A Formulation Of The Nootropic Drug Aniracetam Using 2-Hydroxypropyl-Β-Cyclodextrin Suitable For Parenteral Administration
    153. Designing Nootropic Dipeptides Using An Evolutionary-Genetic Approach
    154. Detection Of Nootropic Activity Indicated By Acute Inhibition Of Orientation Reaction
    155. Development And Pharmacology Of Nootropic And Antidepressive Preparations Based On Eaa Receptor Ligands
    156. Development Of New Drugs Of Plant Origin With Nootropic Action
    157. Development Of New Drugs Of Plant Origin With Nootropic Action
    158. Developmental Dyslexia And The Nootropic Concept
    159. Different Susceptibilities Of Long-Term Potentiations In Ca3 And Ca1 Regions Of Guinea Pig Hippocampal Slices To Nootropic Drugs
    160. Dipeptide Nootropic Agent Gvs-111 Prevents Accumulation Of The Lipid Peroxidation Products During Immobilization
    161. Discussion On Tcm Mechanism Of Nootropic And Brain-Invigorating Chinese Traditional And Herbal Prescriptions And Drugs.
    162. Disposition Of Ethimizol, A Nootropic Drug, In Rats And Mice.
    163. Disposition Of Ethimizol, A Xanthine-Related Nootropic Drug, In Perfused Rat Liver And Isolated Hepatocytes.
    164. Dissociation Of The Anti-Amnesic And Antihypoxic Effects Of Nootropic And Antihypoxic Preparations
    165. Dm235 (Sunifiram): A Novel Nootropic With Potential As A Cognitive Enhancer
    166. Dose-Dependent Pharmacokinetics Of A Xanthine-Related Nootropic Drug, Ethimizol, In Rats
    167. Eeg Mapping In Dementia And Nootropic Drug Research
    168. Effect Of A New Nootropic Agent, Cgs 5649B, On Cognition, Function, And Behavior In Dementia
    169. Effect Of Anti-Epileptic, Nootropic Drugs On The Expression Of Erk2 And Ncam1 In The Hippocampus Changes On The Epileptic Rats With Cognitive Dysfunction
    170. Effect Of Donepezil In Patients With Alzheimer’S Disease Previously Untreated Or Treated With Memantine Or Nootropic Agents In Germany: An Observational Study
    171. Effect Of Drugs Of The Nootropic Class On Rat Behavior After Deprivation Of The Paradoxical Stage Of Sleep
    172. Effect Of Idebenone And Various Nootropic Drugs On Lipid Peroxidation In Rat Brain Homogenate In The Presence Of Succinate
    173. Effect Of Modification Of The N-Terminal Region Of Semax On The Expression Of Nootropic Effect Of Semax Analogs
    174. Effect Of Natural Nootropic And Adaptogen Preparations On The Cortex Bioelectrical Activity In Rats
    175. Effect Of Nootropic Agents On Brain Cholinergic Mechanisms
    176. Effect Of Nootropic Agents On Impulse Activity Of Cerebral Cortex Neurons
    177. Effect Of Nootropic Agents On Serum Biochemical Indices In Intellectually Deficient Children
    178. Effect Of Nootropic Agents On The Brain Bioelectrical Activity And On The Indices Of Neuromediator Metabolism In The Acute Period Of Severe Craniocerebral Trauma
    179. Effect Of Nootropic Agents On The Lowering Of The Spasm Threshold After A Single Ethanol Application
    180. Effect Of Nootropic And Psycho-Stimulants On Children With Infantile Brain Damages.
    181. Effect Of Nootropic Drugs On Age‐Dependent Changes In Transmitter Release
    182. Effect Of Nootropic Drugs On Normal And Disturbed Sleep Of The Elderly: Controlled Studies With Pyridoxilate And Street Noise
    183. Effect Of Nootropic Drugs On Restitution Of Biochemical Changes In Cns Tissue After Paradoxical Sleep Deprivation In Rats.
    184. Effect Of Nootropic Drugs On The Dopamine Release And Dopamine Uptake In Structures Of The Rat Striatum
    185. Effect Of Nootropic Solcoseryl® On Kainic Acid-Induced Excitotoxic Brain Injury
    186. Effect Of Piper Longum On Urinary Metabolites And Its Correlation With Nootropic Activity In Rat Models
    187. Effect Of Piracetam, A Nootropic Agent, On Discrimination Learning Deficits Induced By Parental Undernutrition And Environmental Impoverishment In Young Rats.
    188. Effect Of Piracetam, A Nootropic Agent, On Experimental Gastric Ulcers In Rat.
    189. Effect Of Repeated Application Of Nootropic Drugs On Sleep In Rats.
    190. Effect Of Scopolamine And Nootropic Drugs On Rewarded Alternation In A T-Maze
    191. Effect Of The Combination Of The Benzodiazepine Tranquilizer Medazepam And The Nootropic Agent Meclofenoxate On The Activity Of Rat Brain Muscarinic Receptors
    192. Effect Of The Nootropic Agent Cerebrolysin In Cerebral Ischemia In Rats With Varying Behavioral Reactions In The Open Field Test
    193. Effect Of The Nootropic Drug Oxiracetam On Field Potentials Of Rat Hippocampal Slices.
    194. Effect Of The Novel Dipeptide Nootropic Agent Noopept And Its Metabolite Cyclo-L-Prolylglycine On The Transcallosal Evoked Potential In The Rat Brain
    195. Effect Of The Novel Nootropic And Neuroprotective Dipeptide Noopept On The Streptozotocin-Induced Model Of Sporadic Alzheimer Disease In Rats
    196. Effectiveness Of Nootropic Drugs With Cholinergic Activity In Treatment Of Cognitive Deficit: A Review
    197. Effects Of A Cholinergic Nootropic (Web 1881 Fu) On Event-Related Potentials Recorded In Incidental And Intentional Memory Tasks
    198. Effects Of Aniracetam, A Nootropic Drug, In Senile Dementia
    199. Effects Of Heptapeptide Of The Tuftsin Group With Nootropic Components Of Action And Piracetam On Formation Of Escape Reaction In Normal Conditions And In Conflict …
    200. Effects Of Nebracetam (Web 1881 Fu), A Novel Nootropic , As A M1-Muscarinic Agonist
    201. Effects Of Nefiracetam, A Novel Pyrrolidone‐Type Nootropic Agent, On The Amygdala‐Kindled Seizures In Rats
    202. Effects Of Nicotinic Cholinoreceptor Ligands And Nootropic Drugs On The Spontaneous Exploratory Activity In A Labyrinth In Mice
    203. Effects Of Nootropic Agents On The Performing Of Active Two-Way Avoidance Tasks In Young And Old Rats.
    204. Effects Of Nootropic Agents On Visual Functions And Lacrimal Antioxidative Activity In Patients With Primary Open-Angle Glaucoma
    205. Effects Of Nootropic Drugs For Demented Patients—A Study Using Loreta
    206. Effects Of Nootropic Drugs In A Scopolamine-Induced Amnesia Model In Mice
    207. Effects Of Nootropic Drugs Of Pentylenetetrazol Kindling In Rats
    208. Effects Of Nootropic Drugs On Behavior Of Balb/C And C57Bl/6 Mice In The Exploratory Cross-Maze Test
    209. Effects Of Nootropic Drugs On Brain Cholinergic And Dopaminergic Transmission.
    210. Effects Of Nootropic Drugs On Dopaminergic Systems In The Cns.
    211. Effects Of Nootropic Drugs On Hippocampal And Cortical Bdnf Levels In Mice With Different Exploratory Behavior Efficacy
    212. Effects Of Nootropic Drugs On Some Behavioural And Biochemical Changes After Early Postnatal Hypoxia In The Rat.
    213. Effects Of Nootropic Drugs On The Sleep-Waking Pattern Of The Rat.
    214. Effects Of Red Ginseng Saponins And Nootropic Drugs On Impaired Acquisition Of Ethanol-Treated Rats In Passive Avoidance Performance
    215. Effects Of The Nootropic Agents Adafenoxate And Meclofenoxate On Brain Biogenic Monoamines In Aged Rats.
    216. Effects Of The Nootropic Agents Adafenoxate, Meclofenoxate And The Acetylcholine Precursor Citicholine On The Brain Muscarinic Receptors (Experiments On Rats).
    217. Effects Of The Nootropic Awd 52-39 On The Blood-Brain Transfer Of Leucine, Choline And Glucose In Rats After 14-D Exposure To Ethanol.
    218. Effects Of The Nootropic Drug Nefiracetam On The Gabaa Receptor-Channel Complex In Dorsal Root Ganglion Neurons
    219. Effects Of The Nootropic Nefiracetam On Rat Hippocampal Gaba Release
    220. Effects Of Various Nootropic Candidates On The Impaired Acquisition Of Ethanol-Treated Rats In Step-Through Test
    221. Effects Of Web 1881 Fu, A Novel Nootropic , On Cholinergic And Adrenergic Receptors In The Rat Brain: Action On M1-Muscarinic Receptors
    222. Efficacy Of A Nootropic Spearmint Extract On Reactive Agility: A Randomized, Double-Blind, Placebo-Controlled, Parallel Trial
    223. Efficacy Of The Peptidergic Nootropic Drug Cerebrolysin In Patients With Senile Dementia Of The Alzheimer Type (Sdat)
    224. Electrographic Correlates Of The Antiamnestic Action Of Nootropic Agents Following Deprivation Of The Paradoxical Sleep Phase
    225. Electrophysiological Correlates Of Efficacy Of Nootropic Drugs In The Treatment Of Consequences Of Traumatic Brain Injury In Adolescents
    226. Electrophysiological Evaluation Of The Demented State And The Nootropic Effect Of Ta-0910 By” Automated Fluctuation Analysis” Of The High-Frequency Eeg–Relation …
    227. Endolumbal Nootropic -Ozone Therapy In Complex Treatment Of Patients With Complicated Spinal Injury In Acute Period
    228. Endolumbar Nootropic -Ozone Therapy In Multimodality Treatment Of Patients With A Complicated Spinal Injury At Its Acute Period
    229. Enhancement Of Adenosine‐Induced Relaxant Responses Of The Guinea‐Pig Isolated Taenia Coli And Aortae By A Novel Nootropic Agent By‐1949: Comparison With …
    230. Enhancement Of Neuronal Calcium Channel Currents By The Nootropic Agent, Nefiracetam (Dm-9384), In Ng108-15 Cells
    231. Enhancement Of Nootropic Effect Of Duloxetine And Bupropion By Caffeine In Mice
    232. Establishing Natural Nootropic s: Recent Molecular Enhancement Influenced By Natural Nootropic
    233. Estimation Of Being And Perspective Of Demand On Nootropic Drugs
    234. Estimation Of The Antioxidant Effect Of The Nootropic Dipeptide Noopept On The Model Of Fe2+-Induced Chemiluminescence Of Lipoproteins Of Human Serum In Vitro
    235. Ethical Underpinning And Implications Of “Nootropic ” Concept
    236. Ethylene Bis-Imidazoles Are Highly Potent And Selective Activators For Isozymes Va And Vii Of Carbonic Anhydrase, With A Potential Nootropic Effect
    237. Evaluation Of Antibacterial, Antioxidant And Nootropic Activities Of Tiliacora Racemosa Colebr. Leaves: In Vitro And In Vivo Approach
    238. Evaluation Of Anticonvulsant And Nootropic Effect Of Ondansetron In Mice
    239. Evaluation Of Geriatric Patients With Special Reference To Clinical Trials Of Socalled Nootropic Drugs
    240. Evaluation Of Green Tea For Its Nootropic Activity
    241. Evaluation Of Nootropic Activity Of Aegle Marmelos Extract Using Different Experimental Models In Rats
    242. Evaluation Of Nootropic Activity Of Carica Papaya In Mice
    243. Evaluation Of Nootropic Activity Of Cressa Cretica In Scopolamine-Induced Memory Impairment In Mice
    244. Evaluation Of Nootropic Activity Of Curcuma Longa Leaves In Diazepam And Scopolamine-Induced Amnesic Mice And Rats
    245. Evaluation Of Nootropic Activity Of Ethanolic And Aqueous Root Extracts Of Adhatoda Vasica Nees In Rodents
    246. Evaluation Of Nootropic Activity Of Ethanolic Extract Of Ardisia Blatteri Using Different Experimental Models In Rats
    247. Evaluation Of Nootropic Activity Of Limonia Acidissima Against Scopolamine-Induced Amnesia On Rats
    248. Evaluation Of Nootropic Activity Of Salvia Officinalis L. Extract Using Different Experimental Models In Rats. J
    249. Evaluation Of Nootropic Activity Of Sida Cordifolia In Mice
    250. Evaluation Of Nootropic Activity Of Slimaluma, An Enriched Phytochemical Composition Of Caralluma Fimbriata In Mice
    251. Evaluation Of Nootropic Activity Of Smrithi: A Polyherbal Formulation
    252. Evaluation Of Nootropic Activity Of Two Marketed Drugs Of Bacopa Monnieri In Scopolamine Induced Amnesic Models
    253. Evaluation Of Nootropic Activity Of Vigna Mungo Linn. On Scopolamine Induced Cognitive Dysfunction In Mice
    254. Evaluation Of Nootropic Activity Potential Of Krill Oil In Diazepam Induced Amnesic Mice
    255. Evaluation Of Nootropic Activity Potential Of Krill Oil In Diazepam Induced Amnesic Mice
    256. Evaluation Of Nootropic And Neuroprotective Effects Of Low Dose Aspirin In Rats
    257. Evaluation Of Nootropic Drugs Using Event-Related Potential (P300) In Monkeys
    258. Evaluation Of Nootropic Effect Of Argyreia Speciosa In Mice
    259. Evaluation Of Nootropic Effects Of Aqueous Extract Of Tridax Procumbens Linn On Cognitive Functions In Mice
    260. Evaluation Of Nootropic Effects Of Galantamine And Sildenafil As A Combination In Mice
    261. Evaluation Of Nootropic Potential Of Green Peas In Mice
    262. Evaluation Of Nootropic Potential Of Ocimum Sanctum Linn. In Mice
    263. Evaluation Of Polyherbal Preparation Divya Medha Vati For Nootropic , Anxiolytic And Anticholinesterase Activity
    264. Evaluation Of The Anti-Amyloidogenic Potential Of Nootropic Herbal Extracts In Vitro
    265. Evaluation Of The Nootropic Activity Of Arabica Coffee Pulp Extract (Coffea Arabica)
    266. Evaluation Of The Nootropic Effect Of Mebikar In Clinical Practice
    267. Evalution Of Nootropic And Anti-Nociceptive Activity Of Green Tea In Comparison With Medha Rasayana
    268. Evidence Based Anti-Dementing Activity Of Saraswata Ghrita” A Nootropic Compound From Ayurveda
    269. Evidence For Nootropic Effect Of Br-16A (Mentat [R]), A Herbal Psychotropic Preparation, In Mice
    270. Evidence Pharmacy: Inclusion To The Schemes Of Pharmacotherapy Of The Drug Addicted Patients With Opioid Dependence Of The Nootropic Drugs
    271. Examination Of Lesions In The Urinary Bladder And Kidney Of Dogs Induced By Nefiracetam, A New Nootropic Agent
    272. Examining The Nootropic Effects Of A Special Extract Of Bacopa Monniera On Human Cognitive Functioning: 90 Day Double‐Blind Placebo‐Controlled Randomized Trial
    273. Excitatory Amino Acids And Neuronal Plasticity: Modulation Of Ampa Receptors As A Novel Substrate For The Action Of Nootropic Drugs.
    274. Experience In The Application Of Pramistar, A New Nootropic Preparation, In The Treatment Of Memory Disorders In Patients With Cerebrovascular Pathology
    275. Experimental And Clinical Evaluation Of Nootropic Activity Of Bacopa Monniera Linn.(Brahmi)
    276. Experimental Studies On The Effects Of Nootropic Mixture (Yizhiheji) In Improving Studying & Memorizing And Fighting Aging Of Alzheimer Diseased Rats
    277. Exploring The Nootropic Effect Of Juniperus Recurva Extract: Possible Involvement Of Acetylcholinesterase Inhibition
    278. Facilitation Of Calcium-Dependent Cholinergic Function By Ucb L059, A New “Second Generation” Nootropic Agent
    279. Facilitation Of Evoked Transcallosal Responses By Nootropic Agents
    280. Factors Influencing The Prescribing Of Nootropic Drugs. Results Of A Representative Inquiry In Lower Saxony
    281. Fasoracetam–An Anxiety-Reducing Nootropic
    282. Fast And” Slow” Components Of Psychotropic Activity Of The Drugs With Nootropic Effects
    283. Fast Thin-Layer Densitometric Determination Of The Nootropic Piracetam In Biological Material
    284. Force Factor Forebrain Review: Low Budget Nootropic
    285. Form Edge Review–An Excellent Nootropic Stack
    286. Formulation And Standardization Of Medhya Rasayana–A Novel Ayurvedic Compound Nootropic Drug
    287. Gamma-Aminobutyric Acid Metabolism In The Rat Brain After Administration Of Nootropic Agents
    288. Genius Joy Review: The First “Feel-Good” Nootropic ?
    289. Geriatric Pharmacology. Pharmacokinetics And Pharmacodynamics In The Elderly. Problems With Geriatric And Nootropic Drugs
    290. Ginkgo Biloba Is Not A Smart Drug: An Updated Systematic Review Of Randomised Clinical Trials Testing The Nootropic Effects Of G. Biloba Extracts In Healthy People
    291. Global Dimensional Complexity Of Multi-Channel Eeg Indicates Change Of Human Brain Functional State After A Single Dose Of A Nootropic Drug
    292. Green Tea: Is It Actually A Potent Nootropic ?
    293. Hedychium Spicatum: Evaluation Of Its Nootropic Effect In Mice
    294. Hemidesmus Indicus: Evaluation Of Its Nootropic Effect In Mice
    295. Hemidesmus Indicus: Evaluation Of Its Nootropic Effect In Mice.
    296. Herbal Nootropic Agents.
    297. Hidden Nature Neuro Focus Review: Is It A Good Nootropic ?
    298. High Field Nmr Techniques And Molecular Modelling Study Of The Inclusion Complexes Of The Nootropic Drug Tenilsetam (Cas-997) In Cyclodextrins
    299. High-Performance Liquid Chromatographic Determination Of A New Nootropic , N-(2, 6-Dimethylphenyl)-2-(2-Oxo-1-Pyrrolidinyl) Acetamide, In Human Serum And Urine
    300. How Can You Avoid Inferior Nootropic Supplements
    301. Hunter Focus Review–Is It Really The Best Nootropic Stack?
    302. Huperzine A, A Nootropic Agent, Inhibits Fast Transient Potassium Current In Rat Dissociated Hippocampal Neurons
    303. Huperzine A, A Nootropic Alkaloid, Inhibits N-Methyl-D-Aspartate-Induced Current In Rat Dissociated Hippocampal Neurons
    304. Hypericum Perforatum As A Nootropic Drug: Enhancement Of Retrieval Memory Of A Passive Avoidance Conditioning Paradigm In Mice
    305. Hypoglycemic, Antistress, Anxiolytic, And Nootropic Activity Of Roots Of Rubia Cordifolia Linn
    306. Hypoxia And Memory. Specific Features Of Nootropic Agents Effects And Their Use
    307. I15 Nootropic Effect And Action Mechanisms Of Ginsenoside Rg1, A Smart Drug Candidate
    308. Identification And Evaluation Of A Panel Of Ginsenosides From Different Red Ginseng Extracts With Nootropic Effect
    309. Identifying Nootropic Drug Targets Via Large-Scale Cognitive Gwas And Transcriptomics
    310. Immunostimulant, Cerebroprotective & Nootropic Activities Of Andrographis Paniculata Leaves Extract In Normal & Type 2 Diabetic Rats
    311. Impact Of A Purported Nootropic Supplementation On Measures Of Mood, Stress, And Marksmanship Performance In Us Active Duty Soldiers
    312. Impact Of Nootropic Supplementation On Measures Of Marksmanship Performance In Active Duty Soldiers
    313. Impaired Plasticity Of Hippocampal Synaptic Transmission In Rats Exposed To Prenatal Hypoxia Is Normalized By Treatment With Nootropic Dipeptides
    314. Impairment Of Contextual Fear Conditioning In Rats By Group I Mglurs: Reversal By The Nootropic Nefiracetam
    315. Impairment Of Learning And Memory In Rats Neonatally Injected With 6-Hydroxydopamine (6-Ohda). Effects Of Nootropic Drugs
    316. Impairment Of Learning And Memory In Shuttle Box-Trained Rats Neonatally Injected With 6-Hydroxydopamine. Effects Of Nootropic Drugs.
    317. Improvement Of Avoidance Acquisition By The Nootropic Drug Oxiracetam In Mice.
    318. Improving Mental Performance In An Athletic Population With The Use Of Ārepa®, A Blackcurrant Based Nootropic Drink: A Randomized Control Trial
    319. In Silico And In Vitro Evaluation Of Brain Penetration Properties Of Selected Nootropic Agents
    320. In Silico Evaluation Of The Nootropic Potential Of Anacardic Acid Isolated From The Bark Of Cashew Nut
    321. In Silico Target Identification Of Nootropic Bioactive Compounds From Ayurvedic Herbs
    322. In Vitro And In Vivo Effect Of The Nootropic Agent Adafenoxate On The 5-Ht1 Sites In Different Rat Brain Structures
    323. Influence Of Antiarrhythmic And Nootropic Drugs On Model And Biological Membranes
    324. Influence Of Nootropic Agents And Hyperbaric Oxygenation In The Treatment Of Acute Poisonings With Halogenated Hydrocarbons
    325. Influence Of Nootropic And Antidepressive Drugs On Open Field And Running Wheel Behavior In Spontaneously High And Low Active Mice
    326. Influence Of Nootropic Drugs On Apomorphine-Induced Stereotyped Behaviour In Rats.
    327. Influence Of Nootropic Drugs On Drinking Behaviour In Ethanol-Preferring Mice And Ethanol-Induced Increase Of Seizure Susceptibility.
    328. Influence Of Nootropic Drugs On The Age-Dependent Potassium-Coupling Of Transmitter Release.
    329. Influence Of Nootropic Drugs On The Learning-And Memory-Impairing Effect Of Diethyldithiocarbamate In Albino Rats.
    330. Influence Of Nootropic Drugs On The Memory-Impairing Effect Of Clonidine In Albino Rats.
    331. Influence Of Nootropic Drugs On The Memory-Impairing Effect Of Diethyldithiocarbamate And Clonidine In” Step Down” Passive Avoidance In Albino Rats.
    332. Influence Of Nootropic Drugs On The Stimulus‐Release Relationship Of Dopaminergic Structures
    333. Influence Of Ring Size On The Cognition-Enhancing Activity Of Dm235 And Mn19, Two Potent Nootropic Drugs
    334. Influence On Memory By A New Nootropic Compound
    335. Interaction Between Nootropic Drugs And Methamphetamine On Avoidance Acquisition But Not On Locomotor Activity In Mice
    336. Investigation Of Nootropic Drugs (Pyramem And Orocetam) For Their Teratogenic Effect
    337. Investigation Of The Effects Of Hydration And Amphiphilic Properties Of Nootropic Drugs Of Piracetam And Pramiracetam
    338. Investigations On The Binding Properties Of The Nootropic Agent Pyroglutamic Acid.
    339. Involvement Of Gaba In Nootropic And Anxiolytic Activity Of Saponins Of Albizzia Lebbeck Leaves
    340. Iq² Nootropic Review
    341. Isolation Of Two Ochrobactrum Sp. Strains Capable Of Degrading The Nootropic Drugâ Piracetam
    342. Isolation Of Two Ochrobactrum Sp. Strains Capable Of Degrading The Nootropic Drug—Piracetam
    343. Isolation, Identification, And Nootropic Activity Of Compounds In Alfredia Cernua Chloroform Extract
    344. Just Say “Nootropic ”: The Effects Of Nicotine On Memory And Learning
    345. Large-Scale Cognitive Gwas Meta-Analysis Reveals Tissue-Specific Neural Expression And Potential Nootropic Drug Targets
    346. Large-Scale Cognitive Gwas Meta-Analysis Reveals Tissue-Specific Neural Expression And Potential Nootropic Drug Targets.
    347. Late Consequences Of Neonatal Short-Term Inhibition Of Protein Synthesis In Adult Rats And The Effects Of Nootropic Drugs: A Biochemical And Behavioural Study.
    348. Learning And Memory Impairment In Albino Rats After Potassium Ethylxanthogenate. Effects Of Nootropic Agents.
    349. Literature Review: Caffeine As Mental Stimulant And Nootropic
    350. Ltp Deficiency In Adult Rats Prenatally Exposed To Ethanol Or Hypoxia And Its Correction By Postnatal Treatment With Nootropic Compounds
    351. Lumonol Wisdom–Nootropic Stack For Seniors?
    352. Mechanism Of Action Of Tetrahydro-N, N-Dimethyl-5, 5-Diphenyl-3-Furanemethanamine, A Putative Nootropic , Anti-Epileptic And Antidepressant Compound
    353. Mechanism Of Nootropic Digam Action In Hypofunction Of Brain Dopaminergic System
    354. Medicinal Plants With Nootropic Effect: A Review
    355. Memory Effects Of A Group Of Newly-Synthesized Pyrrolidine Derivatives With Putative Nootropic Effect.
    356. Memory Effects Of The Combination Of Medazepam With Nootropic Agents.
    357. Memory Impairment Induced By Combined Disturbance Of Noradrenergic And Dopaminergic Neurotransmissions: Effects Of Nootropic Drugs.
    358. Memory Retrieval Deficits: Alleviation By Etiracetam, A Nootropic Drug
    359. Mental Retardation Among Children With Cerebral Palsy As Observed In Nepal With A Small Trial With Nootropic (Modafinil)
    360. Meta-Analysis: The Efficacy Of Nootropic Agent Cerebrolysin In The Treatment Of Alzheimer’S Disease
    361. Methodological Approach To The Clinical Evaluation Of Nootropic Drugs
    362. Methodological Approaches To The Design Of Solid Dosage Forms Of Nootropic Action On The Basis Of Plant Raw Materials
    363. Methylazoxymethanol Microencephaly In Rats: Neurochemical Characterization And Behavioral Studies With The Nootropic Oxiracetam.
    364. Mind Lab Pro Review: Should You Buy This Nootropic ?%% Sep%%%% Sitename%%
    365. Mind Lab Pro Review: The Complete Package Nootropic ?
    366. Modern Approach To Development Of Nootropic Agents Based On Γ-Aminobutyric Acid
    367. Modern Problems Of The Pharmacology Of Nootropic Agents: The Status And Outlook
    368. Modulating Effect Of The Nootropic Drug, Piracetam On Stress‐And Subsequent Morphine‐Induced Prolactin Secretion In Male Rats
    369. Modulation Of Ampa Receptor Desensitization By Nootropic Drugs And Endogenous Proteins
    370. Modulation Of Long-Term Memory By Delayed Administration Of The Amide Of L-Pyroglutamyl-D-Alanine, A Nootropic Agent, In Spaced And Massed Training In Rats
    371. Modulation Of The Effects On Learning And Memory Of Nootropic Drugs And Central Stimulants When Applied Together.
    372. Modulation Of The Long-Term Memory By Delayed Administration Of The Nootropic Agent L-Pyroglutamyl-D-Alaninamide During Spaced And Massed Training Of Rats
    373. Modulation Of The Neuronal Nicotinic Acetylcholine Receptor-Channel By The Nootropic Drug Nefiracetam
    374. Molecular Determinants For Drug-Receptor Interactions: 1. Solid-State Structure And Conformation Of The Novel Nootropic Agent 2-Pyrrolidone-N-Acetamide: X-Ray …
    375. Molecular Determinants For Drug—Receptor Interactions: Part 2. An Ab Initio Molecular Orbital And Dipole Moment Study Of The Novel Nootropic Agent Piracetam (2 …
    376. Molecular Docking, Spectroscopic Studies And Quantum Calculations On Nootropic Drug
    377. Molecular Modeling Of Β‐Cyclodextrin Complexes With Nootropic Drugs
    378. Molecular Simplification Of 1, 4-Diazabicyclo [4.3. 0] Nonan-9-Ones Gives Piperazine Derivatives That Maintain High Nootropic Activity
    379. Molecular-Biochemical Mechanisms Of The Effects Of Nootropic Agents
    380. Monitoring The Internet For Nootropic Substances Available To Australian Consumers
    381. Moringa Oleifera Supplemented Diet Modulates Nootropic -Related Biomolecules In The Brain Of Stz-Induced Diabetic Rats Treated With Acarbose
    382. Multiple Mechanisms Underlying Nootropic Drug-Induced Enhancement Of Neuronal Responses Mediated By Activation Of Glutamate Nmda-Type Receptors
    383. Naftidrofuryl Oxalate, Nootropic Effects On The Scopolamine-And The Basal Forebrain Lesion-Induced Amnesia In Rats
    384. Natrol Cognium Review: Totally Over-Hyped Nootropic
    385. Natural Product Synthesis Via Cyclobutanes: Part I, Asymmetric Synthesis Of (+)-Byssochlamic Acid, Part Ii, An Approach To The Nootropic Agent Huperzine A
    386. Negative Regulation Of Opioid Receptor‐G Protein‐Ca2+ Channel Pathway By The Nootropic Nefiracetam
    387. Nerve Growth Factor And Nootropic Drug Cerebrolysin But Not Fibroblast Growth Factor Can Reduce Spatial Memory Impairment Elicited By Fimbria-Fornix Transection: Short …
    388. Neu Nootropic Boost–Does It Work?
    389. Neurochemical Assessments Of The Actions Of Novel Agents Having Nootropic And Anxiolytic Potential: The Measurement In Brain …
    390. Neurocognitive Effect Of Nootropic Drug Brahmi (Bacopa Monnieri) In Alzheimer’S Disease
    391. Neurogenix-Fast Acting Liquid Nootropic
    392. Neurohacker Collective Qualia Mind Review–Great Nootropic Despite Flaws
    393. Neuronal Ca2+ Channels And Nicotinic Ach Receptors As Functional Targets Of The Nootropic Nefiracetam
    394. Neuropathobiology Of Senile Dementia And Mechanism Of Action Of Nootropic Drugs
    395. Neuropharmacological Review Of The Nootropic Herb Bacopa Monnieri
    396. Neurophysiological Analysis Of The Correction By Nootropic Substances Of Disorders In The Bioelectric Activity Of The Brain In Animals During Chronic Administration Of …
    397. Neurophysiological Analysis Of The Effects Of Nooglutil As Opposed To Known Nootropic Drugs
    398. Neuroprotective And Nootropic Actions Of A Novel Cyclized Dipeptide After Controlled Cortical Impact Injury In Mice
    399. Neuroprotective And Nootropic Activity Of Carica Papaya Seeds On Diabetes Induced Cognitive Decline In Rats
    400. Neuroprotective And Nootropic Activity Of Clitorea Ternatea Linn.(Fabaceae) Leaves On Diabetes Induced Cognitive Decline In Experimental Animals
    401. Neuroprotective And Nootropic Drug Noopept Rescues Α-Synuclein Amyloid Cytotoxicity
    402. Neuroprotective Effect Of Kapakh, Representative Of New Nootropic Class Non-Anticholinesterase Organophosphoric Compounds
    403. Neuroprotective Effects Of A New Nootropic Agent Mitochondrin-2
    404. Neuroprotective Properties Of Nootropic Dipeptide Gvs-111 In In Vitro Oxygen-Glucose Deprivation, Glutamate Toxicity And Oxidative Stress
    405. Neuropsychopharmacological Effects Of The Ayurvedic Nootropic Bacopa Monniera Linn.(Brahmi)
    406. New (−)− Cytisine Derivatives With Nootropic Activity
    407. New Aspects Of The Neurophysiological Mechanism Of The Action Of Nootropic Preparations
    408. New Nootropic Preparation From Blood Plasma (Adement): Lack Of Therapeutic Influence On Drosophila Neurodegenerative Model
    409. New Pharmacological Perspectives On Nootropic Drugs
    410. New Trends In The Search For Nootropic Preparations
    411. Nmda Component In The Effects Of Piracetam And New Nootropic Peptide Gvs-111 On The Neocortical And Hippocampal Eeg In Conscious Rats
    412. Nmda-Independent Long-Term Depression Of Synaptic Transmission In The Hippocampus: Mechanisms Of Induction And Effects Of Nootropic Drugs
    413. Non-Linear Dose Effect Relationship In Anxiolytic And Nootropic Activity Of Lithium Carbonate And Nardostachys Jatamansi In Rats
    414. Nonopioid And Neuropathy-Specific Analgesic Action Of The Nootropic Drug Nefiracetam In Mice
    415. Noocube Review⋆ Nootropic Supplement⋆ Does It Work?
    416. Nootropic (Medhya) Effect Of Bhāvita Śaṇkhapuṣpī Tablets: A Clinical Appraisal
    417. Nootropic Action Of Proline-Based Topological Analogs Of Piracetam
    418. Nootropic Action Of Some Antihypertensive Drugs: Computer Predicting And Experimental Testing
    419. Nootropic Activity Of A Novel (-)-Cytisine Derivative (3Ar, 4S, 8S, 12R, 12As, 12Br)-10-Methyl-2-Phenyloctahydro-1H-4, 12A-Etheno-8, 12-Methanopyrrolo [3′, 4′: 3, 4] …
    420. Nootropic Activity Of Acetaminophen Against Colchicine Induced Cognitive Impairment In Rats
    421. Nootropic Activity Of Ajuga Bracteosa Wall On Scopolamine Induced Memory Deficits In Swiss Albino Mice
    422. Nootropic Activity Of Albizzia Lebbeck In Mice
    423. Nootropic Activity Of Bacomind, An Enriched Phytochemical Composition From Bacopa Monnieri
    424. Nootropic Activity Of Butanolic Extract Passiflora Incarnata Leaves
    425. Nootropic Activity Of Calyces Of Hibiscus Sabdariffa Linn
    426. Nootropic Activity Of Caralluma Fimbriata Extract In Mice
    427. Nootropic Activity Of Celastrus Paniculatus Seed
    428. Nootropic Activity Of Crataeva Nurvala Buch-Ham Against Scopolamine Induced Cognitive Impairment
    429. Nootropic Activity Of Ethanolic Extract Of Alangium Salvifolium Leaves On Scopolamine Mouse Model Of Alzheimer’S Disease
    430. Nootropic Activity Of Extracts From Wild And Cultivated Alfredia Cernua
    431. Nootropic Activity Of Glycinergic Derivatives In Relation To Their Dualistic Effects On Cerebral Monoamines
    432. Nootropic Activity Of Hydroalcoholic Extract Of Trapa Bispinosa
    433. Nootropic Activity Of L-33–A Polyherbal Formulation
    434. Nootropic Activity Of Lipid‐Based Extract Of Bacopa Monniera Linn. Compared With Traditional Preparation And Extracts
    435. Nootropic Activity Of Lipid-Based Extract Of Bacopa Monniera Linn. Compared With Traditional Preparation And Extracts.
    436. Nootropic Activity Of Moringa Oleifera Leaves
    437. Nootropic Activity Of N-(2-Acetylaminoethyl) Glycolurils
    438. Nootropic Activity Of Nicotinamide And Its Structural Analogs
    439. Nootropic Activity Of Ocimum Gratissimum In Streptozotocin Induced Amnesia
    440. Nootropic Activity Of Some Quinazoline Amides
    441. Nootropic Activity Of Tuber Extract Of Pueraria Tuberosa (Roxb)
    442. Nootropic Activity Of Ureidoacids And Thiohydantoins
    443. Nootropic Activity Of Vitis Vinifera Juice In Normal And Memory-Impaired Mice Using Spatial Learning And Recognition Memory Paradigms
    444. Nootropic Activity Of Zingiber Officinale In Albino Mice: A Behavioral And Neurochemical Approach.
    445. Nootropic _Affects_Global_Dimensional_Complexity_of.1105.aspx”>Nootropic Affects Global Dimensional Complexity Of Multichannel Eeg
    446. Nootropic Agent Vinpocetine Blocks Delayed Rectified Potassium Currents More Strongly Than High-Threshold Calcium Currents
    447. Nootropic Agents Enhance The Recruitment Of Fast Gabaa Inhibition In Rat Neocortex
    448. Nootropic Agents In The Complex Treatment Of Patients With Traumatic Epilepsy
    449. Nootropic Agents Stimulate Neurogenesis: Brain Cells, Inc.: Wo2007104035
    450. Nootropic And Adaptogenic Effect Of Combined Use Of Cortexin With Polyunsaturated Fatty Acids Concentrate Under Experimental Dislipidemia
    451. Nootropic And Analgesic Effects Of Semax Following Different Routes Of Administration
    452. Nootropic And Anti-Alzheimer’S Actions Of Medicinal Plants: Molecular Insight Into Therapeutic Potential To Alleviate Alzheimer’S Neuropathology
    453. Nootropic And Anti-Amnestic Effect Of Ppa On Scopolamine-Induced Cognitive Impairment In Mice
    454. Nootropic And Antiamnestic Effects Of Tenoten (Pediatric Formulation) In Immature Rat Pups
    455. Nootropic And Antihypoxic Properties Of Novel Derivatives Of 1, 2-Dihydro-3H-1, 4-Benzodiazepin-2-One
    456. Nootropic And Anti-Stress Effects Of Rice Bran Oil In Male Rats
    457. Nootropic And Anxiolytic Activity Of Saponins Of Albizzia Lebbeck Leaves
    458. Nootropic And Anxiolytic Properties Of Endogenous Ligands Of Benzodiazepine Receptors And Their Structural Analogs
    459. Nootropic And Hypophagic Effects Following Long Term Intake Of Almonds (Prunus Amygdalus) In Rats
    460. Nootropic And Neuroprotective Effects Of Dichrocephala Integrifolia On Scopolamine Mouse Model Of Alzheimer’S Disease
    461. Nootropic And Neuroprotective Effects Of Ethanol Extract Of Vateria Indica L Bark On Scopolamine-Induced Cognitive Deficit In Mice
    462. Nootropic And Vasotropic Pharmacotherapy In Neurology: Combination Of Drugs Or Combinational Effect?
    463. Nootropic And Vasotropic Pharmacotherapy In Neurology: Combination Of Drugs Or Combinational Effect?
    464. Nootropic Candidates Inhibit Head-Twitches Induced By Mescaline In Mice
    465. Nootropic Compound L-Pyroglutamyl-D-Alanine-Amide Restores Hippocampal Long-Term Potentiation Impaired By Exposure To Ethanol In Rats
    466. Nootropic Correction Of Disturbances In Learning And Memory Caused By Superhigh Frequency Electromagnetic Radiation
    467. Nootropic Dipeptide Noopept Enhances Inhibitory Synaptic Transmission In The Hippocampus
    468. Nootropic Dipeptide, Noopept Can Modulate Hyperalgesia By Effecting On Spinal Microglia Dependent Brain Derived Neurotropic Factor (Bdnf) And Pro-Bdnf …
    469. Nootropic Dipeptide, Noopept Can Modulate Hyperalgesia By Effecting On Spinal Microglia Dependent Brain Derived Neurotropic Factor (Bdnf) And Pro-Bdnf …
    470. Nootropic Drug Evaluation For General Practice
    471. Nootropic Drug Modulation Of Neuronal Nicotinic Acetylcholine Receptors In Rat Cortical Neurons
    472. Nootropic Drugs
    473. Nootropic Drugs
    474. Nootropic Drugs
    475. Nootropic Drugs And Aging.
    476. Nootropic Drugs And Brain Cholinergic Mechanisms
    477. Nootropic Drugs And Their Action Mechanisms In Relation To The Neuropathobiology Of Senile Dementia. I. Neurotransmission Disorders In The Brain
    478. Nootropic Drugs Glia Signalling Neurorobotics/Prosthetics Brain Imaging Technology Uses And Limitations/Fmri, Eeg Ect… Brain Training?
    479. Nootropic Drugs Have Different Effects On Kindling-Induced Learning Deficits In Rats
    480. Nootropic Drugs In Alzheimer Disease Treatment. New Pharmacological Strategies
    481. Nootropic Drugs In Alzheimer’S Disease: Symptomatic Treatment With Pramiracetam
    482. Nootropic Drugs Positively Modulate Α‐Amino‐3‐Hydroxy‐5‐Methyl‐4‐Isoxazolepropionic Acid‐Sensitive Glutamate Receptors In Neuronal Cultures
    483. Nootropic Drugs Potentiate Nerve Cell Responses Evoked By Nmda-Glutamate Receptor Activation
    484. Nootropic Drugs Reduce Immobility In Behavioural Despair Test In Mice.
    485. Nootropic Drugs: Animal Models For Studying Effects On Cognition
    486. Nootropic Drugs: Evaluation On The Safety And Efficacy
    487. Nootropic Drugs: Methylphenidate, Modafinil And Piracetam–Population Use Trends, Occurrence In The Environment, Ecotoxicity And Removal Methods–A Review
    488. Nootropic Drugs: The Gap Between Preclinical And Clinical Results
    489. Nootropic Effect Of Berberine In Colchicines Induced Experimental Alzheimer’S Disease Model: Effect On Cholinergic Neurotransmission
    490. Nootropic Effect Of Br-16A (Mentat), A Psychotropic Herbal Formulation, On Cognitive Deficits Induced By Prenatal Undernutrition, Postnatal Environmental …
    491. Nootropic Effect Of Combined Application Of Means From Baikal Seal Fat And Cortexin At Cerebral Ischemia
    492. Nootropic Effect Of Complex Phytoremedy «Noophyt» Extract
    493. Nootropic Effect Of Dangsheng, Codonopsis Pilosula (Franch.) Nannf [J]
    494. Nootropic Effect Of Dengyin Nao Tong Capsule On Aging Mice
    495. Nootropic Effect Of Ecuadorian Linseed Oil And Powder (Linum Usitatissimum) On Mus Musculus Mice
    496. Nootropic Effect Of Forsythiaside On A Novel Complex Mouse Model Of Alzheimer Disease And Its Mechanism [J]
    497. Nootropic Effect Of Ginsenoside Rg1 And Its Metabolites And Its Signaling Pathway
    498. Nootropic Effect Of Hypocholesterolemic Drugs In Scopolamine Induced Amnesic Rats
    499. Nootropic Effect Of Ipomoea Aquatic Forsk In Rat Hippocampus
    500. Nootropic Effect Of Meadowsweet (Filipendula Vulgaris) Extracts
    501. Nootropic Effect Of Neferine On Aluminium Chloride–Induced Alzheimer’S Disease In Experimental Models
    502. Nootropic Effect Of Nicotine On Carbon Monoxide (Co)-Induced Delayed Amnesia In Mice
    503. Nootropic Effects Of Ace Inhibitors In Mice
    504. Nootropic Effects Of Filipendula Vulgaris Moench Water Extract Fractions
    505. Nootropic Effects Of New Drug Curdlipid C6
    506. Nootropic Effects Of Psychedelic And Addictive Substances
    507. Nootropic Effects Of Synthetic Flavonoid Derivatives On Scopolamine Induced Memory Impairment In Mice Via Cholinesterase Inhibition And Antioxidant System.
    508. Nootropic Efficacy Of Satvavajaya Chikitsa And Ayurvedic Drug Therapy: A Comparative Clinical Exposition
    509. Nootropic Herbal Formulations For The Treatment Of Alzheimer’S Disease: In Vivo Pharmacological Assay And Molecular Docking Studies
    510. Nootropic Herbs (Medhya Rasayana) In Ayurveda: An Update
    511. Nootropic Investigation: Vinpocetine
    512. Nootropic Medicinal Plants: Therapeutic Alternatives For Alzheimer’S Disease
    513. Nootropic Medicinal Plants; Evaluating Potent Formulation By Novelestic High Throughput Pharmacological Screening (Htps) Method
    514. Nootropic Nanocomplex With Enhanced Blood-Brain Barrier Permeability For Treatment Of Traumatic Brain Injury-Associated Neurodegeneration
    515. Nootropic Nefiracetam Inhibits Proconvulsant Action Of Peripheral‐Type Benzodiazepines In Epileptic Mutant El Mice
    516. Nootropic Pharmacotherapy And Its Role In Solving The Problems Of Women Health
    517. Nootropic Potential Of Alternanthera Sessilis And Clerodendrum Infortunatum Leaves On Mice
    518. Nootropic Potential Of Ashwagandha Leaves: Beyond Traditional Root Extracts
    519. Nootropic Potential Of Bauhinia Variegata: A Systematic Study On Murine Model
    520. Nootropic Potential Of Murraya Koenigii Leaves In Rats
    521. Nootropic Potential Of Silver Nanoparticles Of Boerhaavia Diffusa And Its Ethanolic Extract In High Fat Diet Model Of Dementia In Rats
    522. Nootropic Preparations, The Achievements And New Problems
    523. Nootropic Properties Of Gamma-Aminobutyric Acid Derivatives
    524. Nootropic Signal Transduction Of Ginsenoside Rg1
    525. Nootropic Stacks: The What, The Why And The How
    526. Nootropic Studies Of Ethanolic Extract Of Mimosa Pudica Linn. In Albino Wistar Rats
    527. Nootropic Substances Enhance The N-Methyl-D-Aspartate-Induced Short-Term Potentiation Of Synaptic Transmission In Rat Hippocampal Slices
    528. Nootropic Supplements For Cognitive Improvement How To Prevent Alzheimer’S Disease
    529. Nootropic Treatment And Combined Therapy In Age-Associated Memory Impairment
    530. Nootropic Α7 Nicotinic Receptor Allosteric Modulator Derived From Gabaa Receptor Modulators
    531. Nootropic , Anxiolytic And Cns-Depressant Studies On Different Plant Sources Of Shankhpushpi
    532. Nootropic , Neuroprotective And Neurotrophic Effects Of Phloretin In Scopolamine Induced Amnesia In Mice
    533. Normalization Of The Adaptive Avoidance Reaction In Rats Using Substances With Nootropic Activity
    534. Novel Nootropic Dipeptide Noopept Increases Inhibitory Synaptic Transmission In Ca1 Pyramidal Cells
    535. Novel Nootropic Drug Sunifiram Enhances Hippocampal Synaptic Efficacy Via Glycine‐Binding Site Of N‐Methyl‐D‐Aspartate Receptor
    536. Novel Nootropic Drug Sunifiram Improves Cognitive Deficits Via Cam Kinase Ii And Protein Kinase C Activation In Olfactory Bulbectomized Mice
    537. Novel Small Peptides With Neuroprotective And Nootropic Properties
    538. Novel Validated Analytical Method Based On Potentiometric Transduction For The Determination Of Citicoline Psychostimulant/Nootropic Agent
    539. Oasis Herbals Neurovault Review–Scam Nootropic !
    540. On Some Mechanisms Of Antihypoxic Actions Of Nootropic Drugs.
    541. Organix Labs Focuspower Review–Does This Nootropic Actually Work?
    542. Original Article Nootropic Medicinal Plants; Evaluating Potent Formulation By Novelestic High Throughput Pharmacological Screening (Htps) Method
    543. Original Nootropic Drug Noopept Prevents Memory Deficit In Rats With Muscarinic And Nicotinic Receptor Blockade
    544. Outline For The Evaluation Of Nootropic Drugs
    545. Over-The-Counter Stimulant, Depressant, And Nootropic Use By Veterinary Students
    546. Over-The-Counter Stimulant, Depressant, And Nootropic Use In Veterinary Medical Students
    547. Participation Of Dihydropyridine-Sensitive Calcium Channels In Psychotropic Effects Of Nootropic Drugs
    548. Pass Assisted Prediction And Pharmacological Evaluation Of Novel Nicotinic Analogs For Nootropic Activity In Mice
    549. Peculiarities Of Protein Metabolism At Administration To Prenatal Alcoholized Rats Of Aza-15-Crown-5 Ether Derivative With Nootropic Activity.
    550. Peptide Analogs Of Pyracetam As Ligands For Hypothetical Nootropic Receptors
    551. Peptidergic Nootropic Therapy In Cerebral Palsy Associated With Epilepsy
    552. Performance Enhancement At The Cost Of Potential Brain Plasticity: Neural Ramifications Of Nootropic Drugs In The Healthy Developing Brain
    553. Performance Lab Mind Review–Simple, Effective, Potent–Great Nootropic
    554. Pharmacoeconomical Aspects Of Using Of Antianxious And Nootropic Preparations In Complex Treatment Of Patients With …
    555. Pharmacokinetic And‐Dynamic Studies In Elderlies With A Potential Antihypoxidotic/Nootropic Drug Tenilsetam Utilizing Pharmaco‐Eeg And Psychometry
    556. Pharmacokinetic Properties Of An Innovative Nootropic Agent Based On A Derivative Of 3, 7-Diazabicyclo [3.3. 1] Nonane
    557. Pharmacokinetics And Brain Entry Of Alaptide, A Novel Nootropic Agent, In Mice, Rats And Rabbits
    558. Pharmacokinetics Of A Nootropic Agent, Bmy-21502, And Its Metabolites In Beagle Dogs
    559. Pharmacokinetics Of New Nootropic Acylprolyldipeptide And Its Penetration Across The Blood-Brain Barrier After Oral Administration
    560. Pharmacokinetics Of The Potential Nootropic Drug Of-5858
    561. Pharmacological Exploration Of Nootropic Activity Of Some Indigenous Medicinal Plants
    562. Pharmacological Properties Of Digam—A New Potential Nootropic Drug
    563. Pharmacological Validation Of In-Silico Guided Novel Nootropic Potential Of Achyranthes Aspera L.
    564. Phenibut (Β‐Phenyl‐Gaba): A Tranquilizer And Nootropic Drug
    565. Phytochemical Analysis, Antioxidant, Antistress, And Nootropic Activities Of Aqueous And Methanolic Seed Extracts Of
    566. Phytochemical Analysis, Antioxidant, Antistress, And Nootropic Activities Of Aqueous And Methanolic Seed Extracts Of Ladies Finger (Abelmoschus Esculentus L.) …
    567. Phytochemical Screening And Invivo Nootropic Evaluation Of Carissacarandus Linn. Roots
    568. Phytochemicals Analysis Of Formulated Ayurveda Rasayana Using Nootropic Herbs
    569. Phytopharmacology Of Indian Nootropic Convolvulus Pluricaulis
    570. Piperazines As Nootropic Agents: New Derivatives Of The Potent Cognition-Enhancer Dm235 Carrying Hydrophilic Substituents
    571. Piracetam-Induced Changes In The Functional Activity Of Neurons As A Possible Mechanism For The Effects Of Nootropic Agents
    572. Piracetam-The Original Nootropic
    573. Plants With Nootropic Activity: A Review
    574. Platelet Hyperreactivity And Antiaggregatory Properties Of Nootropic Drugs Under Conditions Of Alloxan-Induced Diabetes In Rats
    575. Platelet-Activating Factor: A New Target Site For The Development Of Nootropic Agents
    576. Possibilities Of Application Of Nootropic Drugs In Treatment Of Epilepsy (Literature Review)
    577. Possibilities Of Correction For Vascular Cognitive Impairments Using Preparations With Combined Nootropic And Vasoactive Action
    578. Possible Role Of Nitric Oxide In The Nootropic And Antiamnesic Effects Of Neurosteroids On Aging-And Dizocilpine-Induced Learning Impairment
    579. Post‐Stroke Dementia: Nootropic Drug Modulation Of Neuronal Nicotinic Acetylcholine Receptors
    580. Potential Nootropic Agents, 4-Alkoxy-2-(1-Piperazinyl) Quinazoline Derivatives
    581. Potential Nootropic Agents: Synthesis Of A Series Of (2-Oxo-1-Pyrrolidinyl) Acetic Acid Piperazides
    582. Potential Nootropic Agents: Synthesis Of Some (2-Oxo-1-Pyrrolidinyl) Acetamides And Some Related Compounds
    583. Potential Nootropic Agents: Synthesis Of Some 1, 4-Disubstituted 2-Oxopyrrolidines And Some Related Compounds
    584. Potential Of Peptidergic Nootropic Therapy In Developmental Dysphasia In Children
    585. Potentiation Of N-Methyl-D-Aspartate-Induced Currents By The Nootropic Drug Nefiracetam In Rat Cortical Neurons
    586. Potentiation Of Nootropic Activity Of Egcg Loaded Nanosuspension By Piperine In Swiss Male Albino Mice
    587. Potentiation Of Α-Amino-3-Hydroxy-5-Methyl-4-Isoxazole Propionic Acid (Ampa)-Selective Glutamate Receptor Function By A Nootropic Drug, Idebenone
    588. Power On Nootropic Review–Suspicious Proprietary Blend!
    589. Practicable And Valid Approach To Evaluate The Efficacy Of Nootropic Drugs By Means Of Rating Scales
    590. Pramiracetam: A Nootropic Agent With Improved Efficacy In Patients With Senile Or Presenile Cognitive Impairment
    591. Preliminary Study On Nootropic Effect Of Vanda Tesselata Roots
    592. Premium Vitality Nootropic Review–Complete Waste Of Time!
    593. Preparation And Screening Of Swarnaprashana For Nootropic Activity
    594. Presynaptic Facilitation By The New Nootropic Drug Nebracetam, Of Ganglionic Muscarinic Transmission In The Dog Cardiac Sympathetic Ganglion.
    595. Progress In The Study Of Nootropic Mechanisms Of Panax Ginseng
    596. Progress On The Study Of The Effects Of Aging And Nootropic Drugs On Membrane Fluidity Of Neurons
    597. Proline-Based Topologic Pyracetam Analogs And Their Nootropic Activity
    598. Proline-Containing Dipeptide Gvs-111 Retains Nootropic Activity After Oral Administration
    599. NProof Of Therapeutical Effectiveness Of Nootropic And Vasoactive Drugs: Advances In Clinical And Experimental Nicergoline Research
    600. Prosopis Cineraria: A Potential Nootropic Agent
    601. Prospective New Nootropic Substances Of The Group Of Amides Of P-Chlorophenoxyacetic And Propionic Acids
    602. Protection From Phenytoin-Induced Cognitive Deficit By Bacopa Monniera, A Reputed Indian Nootropic Plant
    603. Protection Of Cell Proteins Against Free-Radical Attack By Nootropic Drugs: Scavenger Effect Of Pyritinol Confirmed By Electron Spin Resonance Spectroscopy
    604. Psychopharmacological Properties Of Peptides With Nootropic Type Of Action
    605. Psychophysiological Research In Psychiatry And Neuropsychopharmacology. Ii. The Investigation Of Antihypoxidotic/Nootropic Drugs (Tenilsetam And Co-Dergocrine …
    606. Psychostimulant And Nootropic Effect Of Major And Trace Element Composition
    607. Psychotropic Properties Of Nootropic Substances With A Cholinergic Action Component In Single And Long-Term Use
    608. Pyritinol-The Antioxidant, Immune-Enhancing, Anti-Rheumatoid Arthritis Nootropic
    609. Qsar-Modeling Of Bis-Azaaromatic Quaternary Ammonium Organic Salts With Nootropic Activity
    610. Qsar-Modeling Of Bis-Azaaromatic Quaternary Ammonium Organic Salts With Nootropic Activity
    611. Qualia Review–A Revolutionary Nootropic Stack?
    612. Quantitative Evaluation Of The Anxiolytic And Nootropic Effects Of Potassium Orotate In A Wide Range Of Doses
    613. Radioelectroencephalographic Characterization Of Tenilsetam (Cas 997), A Putative Nootropic Compound, In The Freely Behaving Rat
    614. Rapid Inhibition Of Exploratory Movements As A Test Of Nootropic Activity
    615. Regeneration Potential And Major Metabolite Analysis In Nootropic Plant-Bacopa Monnieri (L.) Pennell
    616. Regulatory System Of Brain Chromatin In Nootropic Action
    617. Repurposing Of The Nootropic Drug Vinpocetine As An Analgesic And Anti-Inflammatory Agent: Evidence In A Mouse Model Of Superoxide Anion-Triggered …
    618. Research Article Phytochemical Analysis, Antioxidant, Antistress, And Nootropic Activities Of Aqueous And Methanolic Seed Extracts Of Ladies Finger …
    619. Results Of Treatment With A Broad-Acting Nootropic Preparation On Chronic Diffuse Cerebral Disturbances
    620. Retracted:Nootropic ‐Like Effect Of Ashwagandha (Withania Somnifera L.) In Mice
    621. Reversal Of Scopolamine-Induced Amnesia And Alterations In Energy Metabolism By The Nootropic Piracetam: Implications Regarding Identification Of Brain Structures …
    622. Rhodiola Rosea: Nootropic Powerhouse?
    623. Role Of Functional State Of Neuronal Mitochondria Of Cerebral Cortex In Mechanisms Of Nootropic Activity Of Neuroprotectors In Rats With Alloxan Hyperglycemia
    624. Role Of Medhya Rasayana (Nootropic Herbs) In Present Scenario: An Ayurvedic Overview
    625. Role Of Metabotropic Glutamate Receptor Subclasses In Modulation Of Adenylyl Cyclase Activity By A Nootropic Ns-105
    626. S‐52, A Novel Nootropic Compound, Protects Against Β‐Amyloid Induced Neuronal Injury By Attenuating Mitochondrial Dysfunction
    627. Safety And Tolerability Of The Anxiolytic And Nootropic Drug Phenibut: A Systematic Review Of Clinical Trials And Case Reports
    628. Scopolamine-Induced Amnesia Model: A Possible Anticholinergic Mechanism With Reversibility With Statins And Nootropic Agents
    629. Screening And Personalizing Nootropic Drugs And Cognitive Modulator Regimens In Silico
    630. Screening Of Aqueous And Ethanolic Extracts Of Aerial Parts Of Alternanthera Sessilis Linn. R. Br. Ex. Dc For Nootropic Activity
    631. Screening Of Black Spruce Oilfor Nootropic Activity In Rats
    632. Screening Of Taxillus Tomentosus Ethanolic Extract For Nootropic And Antistress Activity In Rats
    633. Search For A Perfect Nootropic Supplement Combination-Can We Increase Human Intelligence By Nutritional Supplements
    634. Search For Nootropic Substances Based On Molecular Docking Of Methanepyrido[1,2-A][1, 5]Diazocin[(-)-Cytisine] Derivatives To The Active Center Of The Nicotinic …
    635. Semax, An Acth (4-10) Analogue With Nootropic Properties, Activates Dopaminergic And Serotoninergic Brain Systems In Rodents
    636. Senile Dementia Of The Alzheimer Type Treated With Aniracetam: A New Nootropic Agent
    637. Shodhana Decreases Nootropic Activity Of Semecarpus Anacardium
    638. Shortening Of N1 And P3 Latencies In Event‐Related Potentials Observed Coincidentally With Clinical Improvement During Nootropic Medication In A Demented …
    639. Single‐And Multiple‐Dose Pharmacokinetics Of Nefiracetam, A New Nootropic Agent, In Healthy Volunteers
    640. Smartervitamins Brain Support Review: Should You Buy This Nootropic ?
    641. Solid-State Structure And Conformation Of The Nootropic Agent 4-Hydroxy-2-Oxo-1-Pyrrolidineacetamide: X-Ray And Theoretical Self-Consistant Field Molecular Orbital (Scf …
    642. Solid-State Structure And Solution Conformation Of The Nootropic Agent N [2-(N, N-Diisopropylamino) Ethyl]-2-Oxo-1-Pyrrolidinacetamide Sulphate. X-Ray And …
    643. Some Clinical Studies With Piracetam–A “Nootropic ” Substance
    644. Some Considerations Of Different Modes Of Action Of Nootropic Drugs
    645. Space-Oriented Eeg Segmentation Reveals Changes In Brain Electric Field Maps Under The Influence Of A Nootropic Drug
    646. Specific Modulation Of Social Memory In Rats By Cholinomimetic And Nootropic Drugs, By Benzodiazepine Inverse Agonists, But Not By Psychostimulants
    647. Spect Monitoring Of Improved Cerebral Blood Flow During Long-Term Treatment Of Elderly Patients With Nootropic Drugs
    648. Spectral And Frequency Analysis Of The Central Eeg Activity In Parkinson’S Disease Patients With Alzheimer’S Disease: The Development During Nootropic Therapy
    649. Spiro-[4H-Pyrroio[1,2-A][1,4]Benzodiazepine-4,4′-Piperidine] Derivatives As Potential Nootropic Agents: A Simple One-Pot Synthesis
    650. Steady State Visually Evoked Potential (Ssvep) Phase Change As An Index Of Spatial Working Memory Task Performance: The Influence Of Nootropic Supplementation
    651. Structure Of Acetylcholinesterase Complexed With The Nootropic Alkaloid,(–)-Huperzine A
    652. Studies Of The Lipophilic Components Of A Dense Extract Of The Herb Alfredia Cernua And Its Nootropic Properties
    653. Studies On Nootropic Activity And Mechanism Of Emodin-8-O-# Beta#-D-Glucopyranoside
    654. Studies On Nootropic Activity And Mechanism Of Emodin-8-O-?-D-Glucopyranoside
    655. Studies On Nootropic Activity Of Ramipril And Losartan On Scopolamine-Induced Amnesia In Rats
    656. Studies On Nootropic Activity Of Roots Of Tylophora Indica In Mice
    657. Studies On Nootropic Effects Of Various Extracts Of Gmelina Arborea And Cayratia Trifolia
    658. Studies On The Anti-Aging And Nootropic Effects Of Ginsenoside Rg_1 And Its Mechanisms Of Actions [J]
    659. Studies On The Anti-Aging And Nootropic Effects Of Ginsenoside Rg1 And Its Mechanisms Of Actions
    660. Studies On The Metabolism And The Toxicological Analysis Of The Nootropic Drug Fipexide In Rat Urine Using Gas Chromatography–Mass Spectrometry
    661. Studies On The Nootropic And Anti-Amnestic And Anxiolytic-Like Effects Of Gjd-Ppa In Mice
    662. Study Of The Effects Of Nootropic Agents On The Adrenergic Neurotransmission In Smooth Muscles Of Young And Old Animals.
    663. Study Of The Protective Effects Of Nootropic Agents Against Neuronal Damage Induced By Amyloid-Beta (Fragment 25–35) In Cultured Hippocampal Neurons
    664. Study On Nootropic Activity Of Aegle Marmelos L Fruits
    665. Study On Nootropic Activity Of Root Extracts Of Adhatoda Vasica Nees In Mice And Rats
    666. Study On Nootropic Effects Of Mechanical Of 5-Hydroxynicotinic Acid And L-Glutamic Acid And D-, L-Isomers Of Ampasse
    667. Study On The Nootropic Mechanism Of (-) Clausenamide-Influence On The Formation Of Synapses In Mouse Brain
    668. Study On The Nootropic Mechanism Of Ginsenoside Rb1 And Rg1–Influence On Mouse Brain Development
    669. Study On The Nootropic Mechanism Of Ginsenosides
    670. Studying Specific Effects Of Nootropic Drugs On Glutamate Receptors In The Rat Brain
    671. Studying The Nootropic Effects Of Betamecil
    672. Substituted Piperazines As Nootropic Agents: 2-Or 3-Phenyl Derivatives Structurally Related To The Cognition-Enhancer Dm235
    673. Synchronization In The Functioning Of Neurons Of The New Cortex And Hippocampus During Learning Before And After The Administration Of Nootropic Agents And Narcotics
    674. Synthesis And Biological Evaluation Of 3, 7-Diazabicyclo [4.3. 0] Nonan-8-Ones As Potential Nootropic And Analgesic Drugs
    675. Synthesis And Biological Evaluation Of Schiff’S Bases And 2-Azetidinones Of Isonocotinyl Hydrazone As Potential Antidepressant And Nootropic Agents
    676. Synthesis And Inhibitory Activity Of Acylpeptidyl-Prolinal Derivatives Toward Post-Proline Cleaving Enzyme As Nootropic Agents
    677. Synthesis And Nootropic Acitivity Of N-Acyl-4-Phenyel-2-Pyrrolidones
    678. Synthesis And Nootropic Activity Of 2-Oxo-1-Pyrrolidinesulfonic Acid Derivatives.
    679. Synthesis And Nootropic Activity Of New 3-Amino-12-N-Methylcytisine Derivatives
    680. Synthesis And Nootropic Activity Of Oxamoylamino Acids
    681. Synthesis And Nootropic Activity Of Pyrrolidino [1, 2-A] Diazacycloalkanes